Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 12, 1998

View Archived Issues

Amgen: Q4 and FY 1997 highlights

Cel-Sci updates shareholders

Celtrix: Q3 highlights

DiagnoCure: Q4 and FY 1997 highlights

Allergan: FY 1997 highlights

Panretin update

Plant extract DA-9601 protects against NSAID-induced gastric damage

Adenosine agonists with antilipolytic activity described by Glaxo

Icos reveals new cGMP-specific PDE inhibitors

Byk Gulden describes new imidazopyridine PDE IV inhibitors

Celltech reports crosslinked antibodies for cancer indications

Potential new antimigraine agents in development at Allelix

Novel approach to HIV therapy described by ML Laboratories

Zeneca's new antibacterial agents active against resistant pathogens

Inhibitors of secretory PLA2 produced by Streptomyces violaceusniger

Chinese investigators evaluate new MDR-reversing agent

Goralatide: a candidate hematopoietic agent from Beaufour Ipsen

Roche develops orally active anti-HSV agent that targets viral TK

U.S. clearance for naratriptan

CytRx to divest Proceutics subsidiary

Chiroscience and Bristol-Myers Squibb collaborate on MMP inhibitors for cancer

Immunomedics terminates CEA-Scan marketing agreements with Mallinckrodt

Synercid scheduled for FDA committee review next week

Neurocrine Biosciences and Rigel collaborate on gliosis inhibitors

Micrologix, PENCE to collaborate on new antibiotics

Medarex and Schering AG sign antibody agreement